IL102895A0 - Pharmaceutical compositions for lowering blood lipid levels - Google Patents

Pharmaceutical compositions for lowering blood lipid levels

Info

Publication number
IL102895A0
IL102895A0 IL102895A IL10289592A IL102895A0 IL 102895 A0 IL102895 A0 IL 102895A0 IL 102895 A IL102895 A IL 102895A IL 10289592 A IL10289592 A IL 10289592A IL 102895 A0 IL102895 A0 IL 102895A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
blood lipid
lowering blood
lipid levels
levels
Prior art date
Application number
IL102895A
Other languages
English (en)
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of IL102895A0 publication Critical patent/IL102895A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL102895A 1991-08-23 1992-08-21 Pharmaceutical compositions for lowering blood lipid levels IL102895A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74894491A 1991-08-23 1991-08-23
US92975292A 1992-08-12 1992-08-12

Publications (1)

Publication Number Publication Date
IL102895A0 true IL102895A0 (en) 1993-01-31

Family

ID=27115023

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102895A IL102895A0 (en) 1991-08-23 1992-08-21 Pharmaceutical compositions for lowering blood lipid levels

Country Status (7)

Country Link
EP (1) EP0599987A4 (xx)
AU (1) AU2486192A (xx)
CA (1) CA2115675A1 (xx)
IL (1) IL102895A0 (xx)
MX (1) MX9204880A (xx)
NO (1) NO940580L (xx)
WO (1) WO1993003734A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492564A2 (en) * 2001-10-31 2005-01-05 Université Libre de Bruxelles Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents
ES2192495B1 (es) 2002-03-21 2005-02-16 Universidad De Barcelona Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina).
US8895520B2 (en) 2011-10-26 2014-11-25 Universite Nice Sophia Antipolis Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide
MY182801A (en) * 2013-09-26 2021-02-05 Energenesis Biomedical Co Ltd Compound for activating ampk and uses thereof
JP7376951B2 (ja) 2018-08-06 2023-11-09 スカイラーク バイオサイエンス エルエルシー Ａｍｐ活性化プロテインキナーゼ活性化化合物およびその使用
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2026040C3 (de) * 1970-05-27 1975-09-18 Boehringer Mannheim Gmbh, 6800 Mannheim Imidazolribosylcyclophosphate
US3919192A (en) * 1972-05-22 1975-11-11 Icn Pharmaceuticals 5-Amino-4-substituted imidazole nucleotides
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
AU2486192A (en) 1993-03-16
EP0599987A4 (en) 1995-02-01
NO940580L (no) 1994-04-25
NO940580D0 (no) 1994-02-21
WO1993003734A1 (en) 1993-03-04
MX9204880A (es) 1993-04-01
EP0599987A1 (en) 1994-06-08
CA2115675A1 (en) 1993-03-04

Similar Documents

Publication Publication Date Title
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
HU9303143D0 (en) Pharmaceutical compositions
IL104068A0 (en) Pharmaceutical compositions for inhalation
ZA929622B (en) Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level
ZA922834B (en) Pharmaceutical compositions
GB2254554B (en) Pharmaceutical quinone compositions
ZA921093B (en) Pharmaceutical formulations
GB9200253D0 (en) Pharmaceutical compositions
IL87943A0 (en) Pharmaceutical compositions for piperidinoalkanol-decongestant combination
IL102895A0 (en) Pharmaceutical compositions for lowering blood lipid levels
GB9115596D0 (en) Pharmaceutical compositions
GB9120672D0 (en) Pharmaceutical compositions
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
GB9221212D0 (en) Pharmaceutical compositions
GB9200414D0 (en) Pharmaceutical compositions
GB9113805D0 (en) Pharmaceutical compositions
GB9121291D0 (en) Pharmaceutical compositions
GB9109452D0 (en) Pharmaceutical compositions
GB9121989D0 (en) Pharmaceutical compositions
GB9118481D0 (en) Pharmaceutical compositions
GB9100464D0 (en) Pharmaceutical compositions
GB9107278D0 (en) Pharmaceutical compositions
GB9119048D0 (en) Pharmaceutical compositions
GB9123423D0 (en) Pharmaceutical compositions
GB9110884D0 (en) Pharmaceutical compositions